Results 41 to 50 of about 1,678,519 (353)

Intracranial menigioma manifested after delivery in a patient with Hodgkin's disease [PDF]

Vojnosanitetski Pregled, 2006
Background. Intracranial meningioma is rarely reported in the patients treated for Hodgkin’s disease (HD), known to mainly occur in the area of radiation therapy. Case report.
Nagulić Mirjana, Tukić Ljiljana, Ilić Srbislav, Marković Marko   +3 more
doaj   +1 more source

Experience with FLT3 Inhibitor Midostaurin in Newly Diagnosed Acute Myeloid Leukemia Patients

Turkish Journal of Internal Medicine, 2021
Introduction With the introduction of FLT3 inhibitors in recent years, the presence of FLT3 mutation in newly diagnosed acute myeloid leukemia (AML) patients has become more important.
Mehmet Baysal, Nihan Alkis, Serap Baysal
doaj   +1 more source

Acute Myeloid Leukemia (AML): The Role of Intensive Induction Chemotherapy [PDF]

International Journal of Hematology-Oncology and Stem Cell Research, 2004
Intensive induction therapy-in acute myeloid leukemia (AML), as in some other systemic malignancies- is a strategy fundamentally different from post-remission strategies.
Thomas Büchner, Wolfgang Hiddemann, Wolfgang E. Berdel, Bernhard Wörmann, Helmut Löffler, Claudia Schoch, Torsten Haferlach, Wolf-Dieter Ludwig, Georg Maschmeyer, Eva Lengelder, Peter Staib, Reinhard Andreesen, Leopold Balleisen, Detlef Haase, Hartmut Eimermacher, Andrea Schumacher, Carlo Aul, Herbert Rasche, Jens Uhlig, Andreas Grüneisen, Hans Edgar Reis, Joachim Hartlapp, Wolf-Dietrich Hirschmann, Hans-Josef Weh, Hermann-Josef Pielken, Winfried Gassmann, Maria-Cristina Sauerland, Achim Heinecke for the German AML Cooperative Group   +27 more
doaj   +2 more sources

Current concepts of radioimmonotherapy for lymphoma [PDF]

Vojnosanitetski Pregled, 2015
nema
Mihailović Jasna, Ubavić Milan, Trifunović Jasna   +2 more
doaj   +1 more source

Expression Pattern of Long Non-coding RNA Growth Arrest-specific 5 in the Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia

Journal of Medical Biochemistry, 2019
Summary Background Long non-coding RNA growth arrest-specific 5 (GAS5) is deregulated in many cancers because of its role in cell growth arrest and apoptosis.
V. Gasic, B. Stanković, B. Zukic, D. Janić, L. Dokmanovic, N. Krstovski, J. Lazic, Goran Milosevic, M. Lucafò, G. Stocco, G. Decorti, S. Pavlovic, N. Kotur   +12 more
semanticscholar   +1 more source

The long-term remission of rheumatoid arthritis with a single cycle of rituximab [PDF]

Vojnosanitetski Pregled, 2012
Introduction. Rituximab selectively targets CD20+ B cells and presumably protects joints in rheumatoid arthritis. Complete remissions after a single treatment with rituximab, in some cases for longer than 1 year, are observed in only the minority of ...
Glišić Branislava, Knežević Bojana
doaj   +1 more source

Use of corticosteroids for remission induction therapy in patients with new-onset ulcerative colitis in real-world settings

Journal of Market Access & Health Policy, 2019
Background: Corticosteroids may be temporarily effective for ulcerative colitis (UC), but long-term use increases the risk of adverse drug reactions.
M. Okayasu, H. Ogata, Y. Yoshiyama
semanticscholar   +1 more source

Biotin Supplementation Ameliorates Murine Colitis by Preventing NF-κB Activation. [PDF]

, 2020
Background & aimsBiotin is a water-soluble vitamin that is indispensable for human health. Biotin deficiency can cause failure-to-thrive, immunodeficiency, alopecia, dermatitis, and conjunctivitis.
Cahalan, Michael D, Hwang, Michael, Nakasaki, Manando, Sabui, Subrata, Said, Hamid M, Skupsky, Jonathan   +5 more
core  

Glutamine for induction of remission in Crohn's disease [PDF]

Cochrane Database of Systematic Reviews, 2016
Crohn's disease is a chronic relapsing condition of the alimentary tract with a high morbidity secondary to bowel inflammation. Glutamine plays a key role in maintaining the integrity of the intestinal mucosa and has been shown to reduce inflammation and disease activity in experimental models of Crohn's disease.To evaluate the efficacy and safety of ...
Akobeng, Anthony, Elawad, M, Gordon, Morris   +2 more
openaire   +2 more sources

Clinical Significance of Minimal Residual Disease at the End of Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia

Open Access Macedonian Journal of Medical Sciences, 2019
BACKGROUND: Detection of minimal residual disease (MRD) in the early phase of therapy is the most powerful predictor of relapse risk in children with acute lymphoblastic leukaemia (ALL).
A. Jovanovska, K. Martinova, S. Kocheva, Z. Trajkova-Antevska, B. Coneska-Jovanova, I. Panovska-Stavridis, S. Stankovikj, S. Trajkova, A. Dimovski   +8 more
semanticscholar   +1 more source